SARS-CoV-2 3CLpro-IN-20 |
| Catalog No.GC71324 |
SARS-CoV-2 3CLpro-IN-20 (화합물 5g) 는 공가성 중증급성호흡기증후군 코로나바이러스 2형 3CLpro 억제제(IC50: 0.43 μM, Ki: 0.33 μM)의 일종이다.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 878985-00-3
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
SARS-CoV-2 3CLpro-IN-20 (Compound 5g) is a covalent SARS-CoV-2 3CLpro inhibitor (IC50s: 0.43 μM, Ki: 0.33 μM).
References:
[1]. Bao HL, et al. Design and synthesis of isatin derivatives as effective SARS-CoV-2 3CL protease inhibitors. Chem Biol Drug Des. 2023 Aug 10.
Review for SARS-CoV-2 3CLpro-IN-20
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
Review for SARS-CoV-2 3CLpro-IN-20
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *